The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
Summaries of Product Characteristics 1 - 30 of 253 |
|
|
Package leaflet | Status for supply | Name of the medicinal product |
PL
|
Resepti/itsehoito
|
Rabeprazol Krka 10 mg, 20 mg enterotabletti SPC 2024-02-05
|
PL
|
Resepti
|
Rabies-Imovax injektiokuiva-aine ja liuotin, suspensiota varten SPC 2022-07-06
|
|
|
European Medicines Agency's website: Raloxifene Teva - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Rameam 5 mg-5 mg, 5 mg-10 mg, 10 mg-5 mg, 10 mg-10 mg kapseli, kova SPC 2022-09-26
|
PL
|
Resepti
|
Ramipril Hexal 1.25 mg, 2.5 mg, 5 mg, 10 mg tabletti SPC 2021-08-04
|
PL
|
Resepti
|
Ramipril Orion 5 mg, 10 mg tabletti SPC 2021-12-27
|
PL
|
Resepti
|
Ramipril ratiopharm 2.5 mg, 5 mg, 10 mg tabletti SPC 2022-03-22
|
|
|
European Medicines Agency's website: Ranexa (ent. Latixa) - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Ranivisio - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Ranoprin 40 mg, 80 mg tabletti, kalvopäällysteinen SPC 2021-03-26
|
|
|
European Medicines Agency's website: Rapamune - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Rapibloc 20 mg-2ml injektiokonsentraatti, liuosta varten SPC 2022-07-15
|
PL
|
Resepti
|
Rapibloc 300 mg infuusiokuiva-aine, liuosta varten SPC 2024-03-29
|
PL
|
Resepti
|
Rapibloc 300 mg, infuusiokuiva-aine liuosta varten SPC 2020-03-17.docx
|
PL
|
Resepti
|
Rapifen 0,5 mg/ml injektioneste, liuos SPC 2023-03-28.doc
|
|
|
European Medicines Agency's website: Rapiscan - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Rasabon 1 mg tabletti SPC 2022-02-10
|
PL
|
Resepti
|
Rasagilin Krka 1 mg tabletti SPC 2021-12-30
|
PL
|
Resepti
|
Rasagilin Stada 1 mg tabletti SPC 2020-07-21.docx
|
PL
|
Resepti
|
Rasagiline Accord 1 mg tabletti SPC 2022-08-04
|
|
|
European Medicines Agency's website: Rasagiline ratiopharm - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Rasagiline Viatris (ent. Rasagiline Mylan) - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Rasilez - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Ratiograstim - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Rativor 0.5 mg, 1 mg, 2.5 mg tabletti SPC 2023-06-13
|
|
|
European Medicines Agency's website: Ravicti - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Raxone - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: RAYVOW - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Reagila - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Rebetol - EMA: EPAR PI
Finnish Swedish
|
|